Brief: Gentian Diagnostics Q2 EBITDA Up At NOK 8.1 Million
09/07/2026 06:37
BRIEF-Gentian Diagnostics Q2 EBITDA Up At NOK 8.1 Million July 9 (Reuters) - Gentian Diagnostics ASA GENT.OL:
SALES OF NOK 49.8 MILLION IN Q2 2026, UP 14% (20% CURRENCY NEUTRAL ORGANIC GROWTH)
Q2 2026 EBITDA NOK 8.1 MILLION VERSUS NOK 1.7 MILLION YEAR AGO
Further company coverage: GENT.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Gentian Diagnostics Q3 Sales At NOK 51.1 Million
Brief: Gentian Diagnostics Q2 EBITDA At NOK 8.1 Mln
Brief: Gentian Diagnostics Q2 EBITDA Up At NOK 8.1 Million
Brief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership